Potassium

Potassium

SCHEMBL2445679

COc1nc(-c2ccccc2Cl)cc2nc(-c3c(Cl)c(C(C)(C)C)nn3C)[nH]c12.[K]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.73
PTGES O14684 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
PDE10A Q9Y233 9/20 0.33
PDE2A O00408 8/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
TEK Q02763 1/20 0.33
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
AMY1A P0DUB6 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
ABL1 P00519 1/20 0.32
PDE6D O43924 2/20 0.32
PDE6A P16499 2/20 0.32
PDE6G P18545 2/20 0.32
PDE6B P35913 2/20 0.32
PDE6C P51160 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445898 0.99 TRPM8 (0.74) TRPM8PTGESL3MBTL1PDE10APDE2A
SCHEMBL2452068 0.98 TRPM8 (0.73) TRPM8PTGESL3MBTL1PDE10APDE2A
SCHEMBL2452070 0.98 TRPM8 (0.73) TRPM8PTGESL3MBTL1PDE10APDE2A
Hydrochloric Acid SCHEMBL2448734 0.98 TRPM8 (0.73) TRPM8PTGESL3MBTL1PDE10APDE2A
SCHEMBL2445676 0.98 TRPM8 (0.73) TRPM8PTGESL3MBTL1PDE10APDE2A
SCHEMBL2450499 0.93 TRPM8 (0.66) TRPM8PTGESL3MBTL1ABL1
Trifluoroacetic Acid SCHEMBL2445440 0.92 TRPM8 (0.64) TRPM8PTGESL3MBTL1PDE10APDE2A
SCHEMBL2446366 0.89 TRPM8 (0.61) TRPM8PTGESL3MBTL1PDE10APDE2A
SCHEMBL2451463 0.89 TRPM8 (0.60) TRPM8PTGESL3MBTL1PDE10ATEK
SCHEMBL2451470 0.89 TRPM8 (0.60) TRPM8PTGESL3MBTL1PDE10ATEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542552-B1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-11-15 EP disclosed
US-9718820-B2 Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-01 US disclosed
US-20160304518-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-10-20 US disclosed
US-9409915-B2 Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2016-08-09 US disclosed
US-20150158875-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-06-11 US disclosed
US-9023846-B2 Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2015-05-05 US disclosed
US-20140155395-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-06-05 US disclosed
US-8680098-B2 Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-03-25 US disclosed
US-20110218197-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304518-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS TRPM8, TRPV1, TRPA1 TRPM8 1/4885PTGES 988/4885L3MBTL1 3126/4885
US-20150158875-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS TRPM8, TRPV1, TRPA1 TRPM8 1/4885PTGES 988/4885L3MBTL1 3126/4885
US-20140155395-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS TRPM8, TRPV1, TRPA1 TRPM8 1/4885PTGES 988/4885L3MBTL1 3126/4885
US-20110218197-A1 SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS TRPM8, TRPV1, TRPA1 TRPM8 1/4885PTGES 988/4885L3MBTL1 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.